Fundamental Analysis of INVIVYD INC(NASDAQ:IVVD) stock

Fundamental Rating

IVVD gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 565 industry peers in the Biotechnology industry. The financial health of IVVD is average, but there are quite some concerns on its profitability. IVVD is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year IVVD has reported negative net income.

IVVD had a negative operating cash flow in the past year.

1.2 Ratios

Looking at the Return On Assets, with a value of -139.04%, IVVD is doing worse than 83.81% of the companies in the same industry.

IVVD has a Return On Equity of -270.72%. This is in the lower half of the industry: IVVD underperforms 72.24% of its industry peers.

		Industry Rank	Sector Rank
ROA	-139.04%
ROE	-270.72%
ROIC	N/A

ROA(3y)-62.07%

ROA(5y)N/A

ROE(3y)-73.45%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

IVVD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for IVVD has been increased compared to 1 year ago.

There is no outstanding debt for IVVD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -11.35, we must say that IVVD is in the distress zone and has some risk of bankruptcy.

IVVD's Altman-Z score of -11.35 is on the low side compared to the rest of the industry. IVVD is outperformed by 77.05% of its industry peers.

There is no outstanding debt for IVVD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-11.35

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 1.92 indicates that IVVD should not have too much problems paying its short term obligations.

IVVD has a worse Current ratio (1.92) than 76.51% of its industry peers.

A Quick Ratio of 1.58 indicates that IVVD should not have too much problems paying its short term obligations.

IVVD has a Quick ratio of 1.58. This is amonst the worse of the industry: IVVD underperforms 80.43% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.92
Quick Ratio	1.58

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IVVD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -41.01%.

EPS 1Y (TTM)-41.01%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-41.67%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 29.58% on average over the next years. This is a very strong growth

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y12.65%

EPS Next 2Y39.06%

EPS Next 3Y31.98%

EPS Next 5Y29.58%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IVVD. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IVVD. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

IVVD's earnings are expected to grow with 31.98% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y39.06%

EPS Next 3Y31.98%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for IVVD!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

INVIVYD INC

NASDAQ:IVVD (12/24/2024, 8:22:04 PM)

After market: 0.52 +0.01 (+1.98%)

0.5099

+0.04 (+8.24%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)11-14 2024-11-14/bmo

Earnings (Next)N/A N/A

Inst Owners78.39%

Inst Owner ChangeN/A

Ins Owners0.01%

Ins Owner Change0%

Market Cap60.99M

Analysts81.82

Price Target6.64 (1202.22%)

Short Float %5.04%

Short Ratio7.73

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-26.6%

Min EPS beat(2)-48.15%

Max EPS beat(2)-5.04%

EPS beat(4)1

Avg EPS beat(4)-22.05%

Min EPS beat(4)-55.17%

Max EPS beat(4)20.17%

EPS beat(8)3

Avg EPS beat(8)-7.09%

EPS beat(12)6

Avg EPS beat(12)-0.48%

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-61.11%

Min Revenue beat(2)-66.54%

Max Revenue beat(2)-55.69%

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-13.32%

PT rev (3m)-24.74%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-282.6%

EPS NY rev (1m)-51.59%

EPS NY rev (3m)-69.71%

Revenue NQ rev (1m)-91.67%

Revenue NQ rev (3m)-90.69%

Revenue NY rev (1m)-85.52%

Revenue NY rev (3m)-85.52%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	5.27
P/FCF	N/A
P/OCF	N/A
P/B	0.73
P/tB	0.73
EV/EBITDA	N/A

EPS(TTM)-1.96

EYN/A

EPS(NY)-0.12

Fwd EYN/A

FCF(TTM)-1.61

FCFYN/A

OCF(TTM)-1.61

OCFYN/A

SpS0.1

BVpS0.7

TBVpS0.7

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-139.04%
ROE	-270.72%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-62.07%

ROA(5y)N/A

ROE(3y)-73.45%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.07

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	27.89%
Cap/Sales	1.21%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.92
Quick Ratio	1.58
Altman-Z	-11.35

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-41.01%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-41.67%

EPS Next Y12.65%

EPS Next 2Y39.06%

EPS Next 3Y31.98%

EPS Next 5Y29.58%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-40.84%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year57.94%

EBIT Next 3Y23.26%

EBIT Next 5Y17.96%

FCF growth 1Y21.96%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y21.84%

OCF growth 3YN/A

OCF growth 5YN/A

INVIVYD INC (IVVD)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens